Positive News SentimentPositive NewsNASDAQ:HCAT Health Catalyst (HCAT) Stock Price, News & Analysis $2.85 -0.10 (-3.39%) Closing price 09/23/2025 04:00 PM EasternExtended Trading$2.86 +0.00 (+0.18%) As of 09/23/2025 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Health Catalyst Stock (NASDAQ:HCAT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Health Catalyst alerts:Sign Up Key Stats Today's Range$2.85▼$3.0150-Day Range$2.70▼$4.0952-Week Range$2.52▼$9.24Volume404,092 shsAverage Volume777,187 shsMarket Capitalization$200.55 millionP/E RatioN/ADividend YieldN/APrice Target$4.73Consensus RatingHold Company Overview Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information. The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment. Built on cloud-native architecture, DOS provides analytics applications and tools for care management, performance improvement, population health and financial analysis. In addition to its platform technology, Health Catalyst provides professional services including implementation support, data engineering, performance improvement consulting and change management. These services are designed to help health systems and hospitals accelerate adoption of data-driven practices, improve clinical quality and reduce costs through evidence-based interventions. Health Catalyst serves more than 450 healthcare organizations across the United States and has expanded its footprint into select international markets. The company is led by an executive team with deep experience in health IT and population health, and it partners with clients ranging from community hospitals to large integrated health systems to drive measurable improvements in patient outcomes and operational efficiency.AI Generated. May Contain Errors. Read More Health Catalyst Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks87th Percentile Overall ScoreHCAT MarketRank™: Health Catalyst scored higher than 87% of companies evaluated by MarketBeat, and ranked 138th out of 946 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingHold Consensus RatingHealth Catalyst has received a consensus rating of Hold. The company's average rating score is 2.27, and is based on 3 buy ratings, 8 hold ratings, and no sell ratings.Upside PotentialHealth Catalyst has a consensus price target of $4.73, representing about 65.9% upside from its current price of $2.85.Amount of Analyst CoverageHealth Catalyst has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Health Catalyst's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Health Catalyst are expected to grow in the coming year, from ($0.33) to ($0.29) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Health Catalyst is -1.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Health Catalyst is -1.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHealth Catalyst has a P/B Ratio of 0.48. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Health Catalyst's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.66% of the float of Health Catalyst has been sold short.Short Interest Ratio / Days to CoverHealth Catalyst has a short interest ratio ("days to cover") of 7.1.Change versus previous monthShort interest in Health Catalyst has recently increased by 7.14%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHealth Catalyst does not currently pay a dividend.Dividend GrowthHealth Catalyst does not have a long track record of dividend growth. Sustainability and ESG3.8 / 5Environmental Score-0.91 Percentage of Shares Shorted7.66% of the float of Health Catalyst has been sold short.Short Interest Ratio / Days to CoverHealth Catalyst has a short interest ratio ("days to cover") of 7.1.Change versus previous monthShort interest in Health Catalyst has recently increased by 7.14%, indicating that investor sentiment is decreasing significantly. News and Social Media3.2 / 5News Sentiment1.69 News SentimentHealth Catalyst has a news sentiment score of 1.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Health Catalyst this week, compared to 5 articles on an average week.Search Interest3 people have searched for HCAT on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Health Catalyst insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $20,686.00 in company stock.Percentage Held by InsidersOnly 2.60% of the stock of Health Catalyst is held by insiders.Percentage Held by Institutions85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Health Catalyst's insider trading history. Receive HCAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HCAT Stock News HeadlinesHealth Catalyst (NASDAQ:HCAT) General Counsel Sells $20,686.25 in StockSeptember 10, 2025 | insidertrades.com3 Reasons HCAT is Risky and 1 Stock to Buy InsteadSeptember 12, 2025 | msn.comChina’s message to TrumpDid China just fire shots at America? Last week, in Tiananmen Square, China put on a chilling display of military power. Fighter jets, tanks, AI-guided drones — all paraded under the red flag, in front of Vladimir Putin, Kim Jong Un, and more than two dozen world leaders. | Porter & Company (Ad)Okta, Asana, PagerDuty, Appian, and Health Catalyst Shares Plummet, What You Need To KnowSeptember 10, 2025 | finance.yahoo.comHealth Catalyst names Ben Albert as COOSeptember 10, 2025 | msn.comHealth Catalyst Appoints Ben Albert to the Role of President and COOSeptember 10, 2025 | prnewswire.comCyncHealth Nebraska Expands Partnership with Health Catalyst to Accelerate Measurable Improvement in NebraskaSeptember 9, 2025 | prnewswire.comHealth Catalyst Announces Winners of the 2025 Catalyst AwardsAugust 29, 2025 | prnewswire.comSee More Headlines HCAT Stock Analysis - Frequently Asked Questions How have HCAT shares performed this year? Health Catalyst's stock was trading at $7.07 on January 1st, 2025. Since then, HCAT stock has decreased by 59.7% and is now trading at $2.85. How were Health Catalyst's earnings last quarter? Health Catalyst, Inc. (NASDAQ:HCAT) released its earnings results on Wednesday, November, 6th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.10 by $0.03. The firm's quarterly revenue was up 3.5% compared to the same quarter last year. Read the conference call transcript. When did Health Catalyst IPO? Health Catalyst (HCAT) raised $129 million in an IPO on Thursday, July 25th 2019. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers. Who are Health Catalyst's major shareholders? Top institutional investors of Health Catalyst include First Light Asset Management LLC (17.38%), Primecap Management Co. CA (2.85%), Geode Capital Management LLC (2.39%) and Acadian Asset Management LLC (1.67%). Insiders that own company stock include Daniel D Burton, Bryan Truman Hunt, Kevin Lee Freeman, Daniel Lesueur, Benjamin Landry, Jason Alger, Linda Llewelyn and Duncan Gallagher. View institutional ownership trends. How do I buy shares of Health Catalyst? Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Health Catalyst own? Based on aggregate information from My MarketBeat watchlists, some other companies that Health Catalyst investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY), Voyager Therapeutics (VYGR) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings11/06/2024Today9/23/2025Next Earnings (Estimated)11/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryComputer Software Current SymbolNASDAQ:HCAT CIK1636422 Webwww.healthcatalyst.com Phone(801) 708-6800FaxN/AEmployees1,500Year FoundedN/APrice Target and Rating Average Price Target for Health Catalyst$4.73 High Price Target$6.00 Low Price Target$3.50 Potential Upside/Downside+65.9%Consensus RatingHold Rating Score (0-4)2.27 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)($1.51) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$69.50 million Net Margins-31.67% Pretax Margin-31.53% Return on Equity-7.21% Return on Assets-3.28% Debt Debt-to-Equity Ratio0.44 Current Ratio1.83 Quick Ratio1.83 Sales & Book Value Annual Sales$306.58 million Price / Sales0.65 Cash Flow$0.35 per share Price / Cash Flow8.20 Book Value$6.00 per share Price / Book0.48Miscellaneous Outstanding Shares70,370,000Free Float68,544,000Market Cap$200.55 million OptionableOptionable Beta1.53 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:HCAT) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIs This Nvidia’s Next Big Invention? (Picture Inside)Nvidia gave investors a chance to make more than 150 times their money with its AI chips known as graphic proc...InvestorPlace | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Catalyst, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Catalyst With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.